Status:
UNKNOWN
A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pancreatic cancer is one of the most lethal cancers. Survival rates vary largely depending on the stage at which it is diagnosed. EUS is considered one of the most sensitive modalities for pancreatic ...
Detailed Description
Pancreatic cancer is a malignant tumor of the digestive system with insidious onset, rapid progression and very poor prognosis. According to the latest cancer data in China in 2020 released by the Int...
Eligibility Criteria
Inclusion
- All patients meeting the following criteria will be considered for participation in the study:
- Male or female aged 18 or above;
- EUS is needed to further clarify the characteristics of biliopancreatic diseases;
- Patients able to give informed consent were eligible to participate.
- Able and willing to comply with all study process.
Exclusion
- All patients meeting the following criteria will not be considered for participation in the study:
- Has participated in other clinical trials, signed informed consent and was in the follow-up period of other clinical trials.
- Has participated in clinical trials of the drug and is in the elution period of the experimental drug or control drug.
- Drug or alcohol abuse or psychological disorder in the last 5 years.
- Patients in pregnancy or lactation.
- A history of Upper Gastrointestinal surgery.
- Patients with anatomical abnormalities of the upper gastrointestinal tract due to advanced neoplasia
- Patients in whom the presence of clearly defined vital anatomical structures cannot be observed
- Researchers believe that the patient is not suitable to participate in the trial.
Key Trial Info
Start Date :
May 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2022
Estimated Enrollment :
285 Patients enrolled
Trial Details
Trial ID
NCT04892329
Start Date
May 12 2021
End Date
November 30 2022
Last Update
July 5 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000
2
Renmin Hospital of Wuhan University
Wuhan, China, 430060